Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships. The company ...

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

A new startup founded by a former Google DeepMind scientist is exiting stealth with $50 million in funding. Latent Labs is ...

Also in today’s newsletter, ByteDance’s US private equity-backed data centres and Thames Water’s sewage plants ...